Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA

Consensus Needs to Come Down on Intercept (ICPT) after FDA Review is Extended - LeerinkDecember 18, 2015 8:44 AM FDA Pushed Back Intercept Pharma's (ICPT) PDUFA Date; Seeks More Data - Baird Maintains Outperform December 18, 2015 7:41 AM FDA Extends PDUFA Date for Obeticholic Acid for the Treatment of PBCDecember 17, 2015 5:00 PM